Author

R. Riise

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Organism:non-human primate· 1 Assay:proteomics· 1

Frequent Co-Authors

A. E. Hemminki· 1 shared E. M. Forsberg· 1 shared H. Ronnberg· 1 shared J. A. Nilsson· 1 shared J. W. Karlsson· 1 shared L. M. Nilsson· 1 shared L. Ny· 1 shared R. Olofsson Bagge· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. E. Hemminki

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Treatment with anti-HER2 chimeric antigen receptor tumor-infiltrating lymphocytes (CAR-TILs) is safe and associated with antitumor efficacy in mice and companion dogs

E. M. Forsberg, R. Riise, S. Saellstrom, J. W. Karlsson, S. Alsen, V. Bucher, A. E. Hemminki, R. Olofsson Bagge, L. Ny, L. M. Nilsson, H. Ronnberg, J. A. Nilsson

This study evaluates the safety and antitumor efficacy of anti-HER2 CAR-TILs in mice and dogs, showing tumor eradication and tolerability.

bioRxiv · Sep 11, 2022Cancer Biology